Topic Editor: Sara Millican, MBBS
Review Date: 12/26/2012
Definition
Pediatric pneumonia is a lower respiratory tract infection with consolidation of the alveolar spaces, in a patient less than 18 years of age.
Description
- Infection of the lower respiratory tract in an infant, child or adolescent with involvement of the airways and pulmonary parenchyma with consolidation of the alveolar spaces
- Infection is often due to organisms which colonize the upper respiratory tract. Infection can also occur with organisms being inhaled and bypassing the host's immune and non-immune defense mechanisms
- Infection may originate in the lung or rarely be a complication of a contiguous systemic inflammatory process
- History and physical exam help assess both the likely causative organism and infection severity
- Severity ranges from mild disease which can be treated as an outpatient, to severe disease which requiring intensive care with respiratory support
- Disease can result from a variety of organisms including bacteria, viruses, and fungi
- Distribution of disease depends on the organism:
- It is important to note that any etiological agent can result in any distribution of disease; the items below are the most common patterns
- Interstitial (Mycoplasma pneumonia, viruses)
- Lobar (Streptococcus pneumoniae)
- Abscesses (Staphylococcus aureus) or diffuse (Pneumocystis jirovecii)
Epidemiology
Incidence/Prevalence
- The World Health Organization (WHO) estimates worldwide incidence of 156 million cases of pediatric pneumonia yearly in children <5 years, with ~20 million cases severe enough to require hospital admission
- Among children <5 years, approximately 2 million deaths due to pneumonia occur each year. Most of these deaths are in developing regions of Africa and southeast Asia
- The rates in developed countries are considerably lower, with total incidence of disease closer to 2.6 million per year, with approximately 3,000 deaths per year in children <5 years
Age
- Children aged <5 years are at greater risk of infection and related mortality
- Influenza-associated hospitalizations in the U.S. are higher among children aged <5 years, and similar to those of older adults
Risk factors:
- Aspiration risk (altered level of consciousness, swallowing disorder)
- Asthma
- Bronchopulmonary dysplasia
- Cerebral palsy
- Congenital pulmonary malformations
- Cystic fibrosis
- Immunocompromised status
- Seizure disorder
- Selective IgA deficiency
- Sickle cell anemia
- Tracheoesophageal fistula
Etiology
- May be caused by a variety of organisms; however likely causative organisms can be predicted based upon patient age, exposures, risk factors and immunization history
- Patients may have co-infection with more than one type of organism, e.g. bacteria and virus, with studies showing mixed infections ranging from 23%-66% of children admitted to hospital with community-acquired pneumonia
Aged <4 weeks:
Organisms responsible for pneumonia in children aged <4 weeks include
- Cytomegalovirus (CMV)
- Chlamydia trachomatis
- Enteric gram-negative organisms
- Group B Streptococcus species
- Herpes simplex virus
- Listeria monocytogenes
- Pseudomonas aeruginosa
- Respiratory syncytial virus (RSV)
- Rubella
- S. aureus
- Syphilis
Aged 4 weeks to 3 months:
Most pathogens in this age group are community acquired bacteria. Organisms responsible include
- Bordetella pertussis
- Chlamydia trachomatis
- Haemophilus influenzae
- Human metapneumovirus
- Parainfluenza virus
- RSV
- S. aureus
- Streptococcus pneumoniae
Age 3 months to 8 years:
The most common cause of pneumonia is viruses:
- Adenovirus
- Human metapneumovirus
- Influenza virus
- Parainfluenza virus
- RSV
Bacterial causes include:
- B. pertussis
- Group A streptococci
- H. influenzae in non-immunized children
- M. pneumoniae
- M. tuberculosis
- S. aureus
- S. pneumoniae
Age >8 years:
- Mycoplasma pneumoniae is most common cause of pneumonia in this age group
- Pneumonia due to bacterial pathogens include:
- C. pneumoniae
- L. pneumophilia (rare except malignancy)
- M. pneumoniae
- M. tuberculosis
- S. pneumoniae
- S. aureus
- S. pyogenes
- Viral infections in older children are generally mild and self-limited, however infection with influenza may lead to bacterial superinfection
Immunocompromised:
- An immunocompromised status (e.g., HIV, cancer) increases the risk for pneumonias with opportunistic agents e.g.
- Klebsiella pneumoniae
- Legionella pneumophilia
- Mycobacterium tuberculosis
- Mycoplasma avium complex
- Pneumocystis jirovecii
- Pseudomonas aeruginosa
- In patients with cystic fibrosis, S.aureus and Burkholderia cepacia are also potential causes
Recent immigrants from developing countries:
- B. pertussis
- H. influenzae
- Mycoplasma tuberculosis
Less common:
- Fungal (coccidioidomycosis, histoplasmosis)
- Rickettsia (Q fever)
Blood tests findings
Basic laboratory tests and radiology may not be indicated for simple, uncomplicated pneumonia as it adds a little over careful clinical management of such cases.
- Complete blood count (CBC) with differential:
- Suggestive of infective process; patients with a bacterial infection tend to have leukocytosis with left shift; however septic patients may have a leukopenia
- Patients with B. pertussis generally have a markedly raised white blood cell (WBC) count with a predominance of lymphocyte in early disease
- Blood culture:
- Not indicated for uncomplicated pneumonia to be treated in the outpatient setting
- Recommended for all patients with severe community-acquired pneumonia, however the results are rarely positive and when positive rarely modify empiric therapy
- Indicated in all patients <1 month age due to the hematogenous origin and spread of organisms in this group
- Inflammatory markers:
- Inflammatory markers are useful in septic neonates. Although some recommendations for use of CRP to monitor the course of pneumonia exist; this hasn't been shown to be of any value over competent clinical assessment in most cases
- If performed; generally CRP is the most appropriate test due to its superior specificity and sensitivity. There is no value to obtaining both a CRP and ESR
- Note that these markers may have delayed rise in acute illness
- Serology:
- Can be used for diagnosis of species such as Chlamydia species, M. pneumoniae, and Legionella (low yield in cultures)
- Infection may be indicated by a four-fold increase in serum and convalescent titers
Other laboratory test findings- Sputum (gram stain and culture)
- Sputum for gram stain and culture may be obtained in hospitalized patients with suspected bacterial infection. It is of highest value in complex cases such as severe disease, complicating factors (significant recent antibiotic use, cystic fibrosis, immunosuppression)
- In most cases this test fails to yield a definitive result nor impact empiric therapy
- Not used in patients <10 years as sputum generally not produced and if so likely to be contaminated by oral flora
- Rapid urinary antigen tests:
- Test provides high specificity and sensitivity
- Recommended in patients with severe disease
- Polymerase chain reaction (PCR):
- Noninvasive test which has advantages over bronchoalveolar lavage or lung aspirate. May facilitate a more rapid diagnosis for C. pneumonia or M. pneumoniae
- Cold agglutinin testing:
- Serologic test useful to support the diagnosis of M. pneumoniae infection
- Test has low specificity, and is positive in about 1 in 2 cases of mycoplasma infection
- Rapid viral diagnostic tests:
- Nasopharyngeal specimens are recommended for viral isolation
- More sensitive than culture, and may detect low quantities of viral ribonucleic acid (RNA)
Radiographic findings
- Chest radiograph:
- May not be required in uncomplicated cases where history and examination are consistent with pneumonia
- Chest x-ray is the modality of choice when pneumonia is suspected, but findings are inconsistent and/or complications are suspected
- The x-ray is abnormal at presentation in ~40% of pneumonia cases
- The typical pattern is that of alveolar/lobular infiltrates with air bronchograms
- Diffuse infiltrates are more common with atypical organisms or viruses
- The x-ray generally cannot differentiate between bacterial and viral pneumonia
- Computed tomography (CT):
- Most useful modality for defining extent of complications of pneumonia and/or in severe disease to which antibiotic treatment fails to elicit a response
- Chest CT can be used to monitor for lung nodules, or cavitation within a lung infiltrate and to evaluate for underlying neoplasm
- Chest CT is not a first line test due to the radiation dose. It is appropriate in complex, severe, unusual, or prolonged cases
Other diagnostic test findings
- Bronchoscopy:
- Bronchoscopic samples of lower respiratory secretions are indicated in patients with complications, persistent hypoxia, or no response to therapy or presence of pulmonary abscess
- Cultures of endotracheal aspirates or expectorated sputum may be used to assess for drug-resistant or atypical pathogens
- Thoracentesis:
- Performed for both diagnostic and therapeutic value in children with parapneumonic effusions
General treatment items
- The age of the patient and severity of disease and other issues (hydration, hypoxia, need for IV therapy) determine the location (hospital versus home) and nature of treatment required
- Neonates are almost exclusively treated as inpatients
- Initial treatment:
- Identify and provide therapy for respiratory distress, hypoxemia or hypercarbia
- Pulse oximetry should be performed and oxygen should be administered to achieve saturations above 94-95%
- Monitor oxygen saturation by pulse oximeter continuously for children with increased work of breathing or significant distress
- Effectiveness of pulmonary ventilation can be assessed via a blood gas to evaluate the PCO2 (venous is adequate)
- Children who are severely ill i.e. unable to maintain adequate oxygenation, inadequate ventilation or who have a decreased level of consciousness, should undergo intubation for clinical respiratory failure
- Children with septic shock or severe sepsis may also benefit from intubation and ventilation
- IV hydration, correction of dehydration and resuscitation (0.9% NS or lactated ringers in 10 - 20 mL/kg boluses) is required if the patient is in shock or hypovolemic. In sepsis, multiple boluses and vasopressors are commonly requiredA bedside glucose should be obtained in all critically ill infants and toddlers. If hypoglycemic is present, administer dextrose 10% solution at 5 mL/kg intravenous (IV) bolus for neonates or dextrose 25% at 2 mL/kg IV bolus for toddlers
- Critically ill children requiring ventilation should be promptly administered appropriate antibiotics
- Delay may be associated with longer duration of ventilation, ICU stay and total length of hospitalization
- Children with reactive airway disease need specific treatment with bronchodilators (e.g. albuterol)
- Perform thoracocentesis if a significant pleural effusion is present surrounding the pneumonia, for both diagnostic and therapeutic purposes
- Empiric antibiotic treatment :
- Treatment should be based on likely etiology, age and clinical status of the patient
- Antibiotic treatment is usually not required in mild cases in preschool aged children as most cases are viral
Outpatient treatment
- Age 1 - 3 months:
- Erythromycin
- Macrolide (azithromycin or clarithromycin)
- Age 4 months -18 years:
- Amoxicillin
- Amoxicillin-clavulanate (2nd line)
- If atypical organism suspected add:
- Macrolide (azithromycin or clarithromycin) OR
- Doxycycline (only if age>8 years)
Start IV antibiotic therapy for moderate to severely ill children who need admission:
- Neonate:
- Ampicillin and gentamicin +/- cefotaxime
- Azithromycin or erythromycin for suspected C. trachomatis or B. pertussis pneumonia
- Add vancomycin if MRSA a concerny
- Age 1-3 months:
- Erythromycin or azithromycin as 1st line agent + cefotaxime if febrile
- Ampicillin if lobar pneumonia to cover for S.pneumoniae
- Age 4 months - 18 years:
- Ampicillin OR
- Cefotaxime or Ceftriaxone as alternative or if not fully immunized
- Vancomycin may be added for suspected or confirmed penicillin-resistant S. pneumoniae or MRSA
- Macrolide may be added (i.e., azithromycin, clarithromycin or erythromycin) for suspected M. pneumoniae
Consult with local infectious disease service if poor response, unusual organisms, or in immunocompromised or special patient groups.
Medications indicated with specific doses
Penicillins
- Amoxicillin[Oral]
- Amoxicillin/clavulanate
- Ampicillin [IM/IV]
Cephalosporins
- Cefotaxime [IM/IV]
- Ceftriaxone [IM/IV]
Glycopeptides
Macrolides
- Azithromycin [Oral]
- Azithromycin [IV]
- Clarithromycin:
- Erythromycin [Oral]
Aminoglycoside
Disposition
Admission criteria
- Apnea
- Dehydration and vomiting
- Hypoxia or respiratory distress
- Immunocompromised status
- Infants aged <2 months with cough and/or difficult or rapid breathing
- Infants aged <6 months with lobar pneumonia
- Poor social support or family dynamics
- Pleural effusion
- Poor response to outpatient oral therapy
- Toxic or septic appearance
Discharge criteria - Patients are usually discharged when there is no concern of hypoxia, respiratory distress, dehydration, vomiting, or noncompliance
- The patient has to be able to maintain hydration and take the prescribed medication
- There must be reliable family and social supports and appropriate precautions of indications to return for urgent or routine medical attention
- Ability to attend follow up in 1-2 days